Figure 2.
First and subsequent CVD, MI, or stroke among patients randomized to vorapaxar or to placebo. CVD indicates cardiovascular death; MI, myocardial infarction; rehosp, rehospitalization; revasc, revascularization.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.